Higher Buprenorphine Doses Reduce Acute Care for Opioid Use Disorder
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — Higher doses of buprenorphine for patients with...
Read More
Pharmacy
Olanzapine, Prochlorperazine Both Alleviate Refractory Chemo-Related Nausea
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — Olanzapine may be better than prochlorperazine...
Read More
2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer
TUESDAY, Oct. 1, 2024 (HealthDay News) — The 2023 cisplatin shortage led to a shift in...
Read More
FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease
TUESDAY, Oct. 1, 2024 (HealthDay News) — The U.S. Food and Drug Administration has approved...
Read More
1999 to 2020 Saw Decline in Menopausal Hormone Therapy Use
MONDAY, Sept. 30, 2024 (HealthDay News) — From 1999 to 2020, there was a decrease in...
Read More
Measles Cases in England Consistent With Waning of Vaccine Immunity
MONDAY, Sept. 30, 2024 (HealthDay News) — Measles cases in England are consistent with the...
Read More
Guideline Developed for Opioid Prescribing in Children With Acute Pain
MONDAY, Sept. 30, 2024 (HealthDay News) — In a clinical practice guideline issued by the...
Read More
FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C
MONDAY, Sept. 30, 2024 (HealthDay News) — The U.S. Food and Drug Administration has approved...
Read More
Anti-CD20 Therapy Shows No Effect on Disability Progression in MS
THURSDAY, Sept. 26, 2024 (HealthDay News) — For patients with primary progressive multiple...
Read More
FDA Approves Bimzelx for Three New Indications
THURSDAY, Sept. 26, 2024 (HealthDay News) — The U.S. Food and Drug Administration has...
Read More
FDA Approves Injectable Ocrevus Zunovo for Relapsing, Progressive MS
THURSDAY, Sept. 26, 2024 (HealthDay News) — The U.S. Food and Drug Administration has...
Read More
Childhood Vaccination Coverage Lower for Children Born in 2020, 2021
THURSDAY, Sept. 26, 2024 (HealthDay News) — Children born in 2020 to 2021 had lower coverage...
Read More
Novo Nordisk CEO Grilled by Congress Over Price of Ozempic
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — During a tense hearing before a Senate...
Read More
Semaglutide Beneficial for Hidradenitis Suppurativa in Patients With Obesity
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — For patients with obesity, the addition of...
Read More
Early Adoption of DOAC Dashboard Reduces Off-Label Prescribing
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — Early adoption of the direct oral anticoagulant...
Read More
Semaglutide May Lower Risk for Opioid Overdose in T2DM, Opioid Use Disorder
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — For patients with type 2 diabetes (T2D) and...
Read More
UBE Microdiscectomy Beneficial for Lumbar Disc Herniation
TUESDAY, Sept. 24, 2024 (HealthDay News) — For adults with symptomatic lumbar disc...
Read More
Skeletal Muscle Relaxants Beneficial for Only Certain Conditions
TUESDAY, Sept. 24, 2024 (HealthDay News) — Long-term use of skeletal muscle relaxants (SMRs)...
Read More
14 Percent of U.S. Adults Meet Criteria for Absolute Iron Deficiency
TUESDAY, Sept. 24, 2024 (HealthDay News) — A considerable proportion of U.S. adults has...
Read More
Few U.S. Jails Offer Medications for Opioid Use Disorder
TUESDAY, Sept. 24, 2024 (HealthDay News) — Few U.S. jails offer medications for opioid use...
Read More